Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity

Srinivasa Subramaniam, Katherine M. Sixt, Roxanne Barrow, Solomon H. Snyder^*

Abstract: Huntington’s disease (HD) is caused by a polyglutamine repeat in the protein huntingtin (Htt) with mutant Htt (mHtt) expressed throughout the body and similarly in all brain regions. Yet, HD neuropathology is largely restricted to the corpus striatum. We report that the small guanine nucleotide–binding protein Rhes, which is localized very selectively to the striatum, binds physiologically to mHtt. Using cultured cells, we found Rhes induces sumoylation of mHtt, which leads to cytotoxicity. Thus, Rhes-mHtt interactions can account for the localized neuropathology of HD.

The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205, USA.

^* To whom correspondence should be addressed. E-mail: ssnyder{at}jhmi.edu

A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.

B. Lu and J. Palacino (2013)
FASEB J 27, 1820-1829
 |  Abstract »  |  Full Text »  |  PDF »

Rhes Deletion Is Neuroprotective in the 3-Nitropropionic Acid Model of Huntington's Disease.

R. G. Mealer, S. Subramaniam, and S. H. Snyder (2013)
J. Neurosci. 33, 4206-4210
 |  Abstract »  |  Full Text »  |  PDF »

Dexras1, a Small GTPase, Is Required for Glutamate-NMDA Neurotoxicity.

Y. Chen, R. S. Khan, A. Cwanger, Y. Song, C. Steenstra, S. Bang, J. H. Cheah, J. Dunaief, K. S. Shindler, S. H. Snyder, et al. (2013)
J. Neurosci. 33, 3582-3587
 |  Abstract »  |  Full Text »  |  PDF »

PGC-1{alpha} Negatively Regulates Extrasynaptic NMDAR Activity and Excitotoxicity.

C. Puddifoot, M.-A. Martel, F. X. Soriano, A. Camacho, A. Vidal-Puig, D. J. A. Wyllie, and G. E. Hardingham (2012)
J. Neurosci. 32, 6995-7000
 |  Abstract »  |  Full Text »  |  PDF »

Small Changes, Big Impact: Posttranslational Modifications and Function of Huntingtin in Huntington Disease.

D. E. Ehrnhoefer, L. Sutton, and M. R. Hayden (2011)
Neuroscientist 17, 475-492
 |  Abstract »  |  PDF »

Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways.

A. Teixeira-Castro, M. Ailion, A. Jalles, H. R. Brignull, J. L. Vilaca, N. Dias, P. Rodrigues, J. F. Oliveira, A. Neves-Carvalho, R. I. Morimoto, et al. (2011)
Hum. Mol. Genet. 20, 2996-3009
 |  Abstract »  |  Full Text »  |  PDF »

Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.

A. Davranche, H. Aviolat, G. Zeder-Lutz, D. Busso, D. Altschuh, Y. Trottier, and F. A. C. Klein (2011)
Hum. Mol. Genet. 20, 2795-2806
 |  Abstract »  |  Full Text »  |  PDF »

Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease.

P. M. Gaughwin, M. Ciesla, N. Lahiri, S. J. Tabrizi, P. Brundin, and M. Bjorkqvist (2011)
Hum. Mol. Genet. 20, 2225-2237
 |  Abstract »  |  Full Text »  |  PDF »

Huntington's Disease.

S. Finkbeiner (2011)
Cold Spring Harb Perspect Biol 3, a007476
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs.

D. Yang, C.-E. Wang, B. Zhao, W. Li, Z. Ouyang, Z. Liu, H. Yang, P. Fan, A. O'Neill, W. Gu, et al. (2010)
Hum. Mol. Genet. 19, 3983-3994
 |  Abstract »  |  Full Text »  |  PDF »

Polyglutamine Diseases: Where does Toxicity Come from? What is Toxicity? Where are We Going?.

T. Takahashi, S. Katada, and O. Onodera (2010)
J Mol Cell Biol 2, 180-191
 |  Abstract »  |  Full Text »  |  PDF »

Rhes, a Physiologic Regulator of Sumoylation, Enhances Cross-sumoylation between the Basic Sumoylation Enzymes E1 and Ubc9.

S. Subramaniam, R. G. Mealer, K. M. Sixt, R. K. Barrow, A. Usiello, and S. H. Snyder (2010)
J. Biol. Chem. 285, 20428-20432
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease.

C. Zuccato, M. Valenza, and E. Cattaneo (2010)
Physiol Rev 90, 905-981
 |  Abstract »  |  Full Text »  |  PDF »

Differential Effects of Sumoylation on Transcription and Alternative Splicing by Transcription Elongation Regulator 1 (TCERG1).

M. Sanchez-Alvarez, M. Montes, N. Sanchez-Hernandez, C. Hernandez-Munain, and C. Sune (2010)
J. Biol. Chem. 285, 15220-15233
 |  Abstract »  |  Full Text »  |  PDF »

SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7.

A. Janer, A. Werner, J. Takahashi-Fujigasaki, A. Daret, H. Fujigasaki, K. Takada, C. Duyckaerts, A. Brice, A. Dejean, and A. Sittler (2010)
Hum. Mol. Genet. 19, 181-195
 |  Abstract »  |  Full Text »  |  PDF »

Detection, Validation, and Downstream Analysis of Allelic Variation in Gene Expression.

D. C. Ciobanu, L. Lu, K. Mozhui, X. Wang, M. Jagalur, J. A. Morris, W. L. Taylor, K. Dietz, P. Simon, and R. W. Williams (2010)
Genetics 184, 119-128
 |  Abstract »  |  Full Text »  |  PDF »

SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle.

C. Figueroa-Romero, J. A. Iniguez-Lluhi, J. Stadler, C.-R. Chang, D. Arnoult, P. J. Keller, Y. Hong, C. Blackstone, and E. L. Feldman (2009)
FASEB J 23, 3917-3927
 |  Abstract »  |  Full Text »  |  PDF »

Science Signaling Podcast: 21 July 2009.

W. Wong and A. M. VanHook (2009)
Science Signaling 2, pc13
 |  Abstract »  |  Full Text »

Previously Unknown Protein Contributes to Huntington Disease.

(2009)
Journal Watch (General) 2009, 5
 |  Full Text »

Previously Unknown Protein Contributes to Huntington Disease.

Anthony L. Komaroff, MD and Anthony L. Komaroff, MD (2009)
Journal Watch 2009, JW200906300000005
 |  Full Text »